These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11823443)

  • 1. The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics.
    Dickinson P; Smith SN; Webb S; Kilanowski FM; Campbell IJ; Taylor MS; Porteous DJ; Willemsen R; de Jonge HR; Farley R; Alton EW; Dorin JR
    Hum Mol Genet; 2002 Feb; 11(3):243-51. PubMed ID: 11823443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutation (G480C) in the CFTR gene associated with protein mislocalization but normal chloride channel activity.
    Smit LS; Strong TV; Wilkinson DJ; Macek M; Mansoura MK; Wood DL; Cole JL; Cutting GR; Cohn JA; Dawson DC
    Hum Mol Genet; 1995 Feb; 4(2):269-73. PubMed ID: 7757078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for the cystic fibrosis delta F508 mutation.
    van Doorninck JH; French PJ; Verbeek E; Peters RH; Morreau H; Bijman J; Scholte BJ
    EMBO J; 1995 Sep; 14(18):4403-11. PubMed ID: 7556083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
    French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
    J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.
    Faure G; Bakouh N; Lourdel S; Odolczyk N; Premchandar A; Servel N; Hatton A; Ostrowski MK; Xu H; Saul FA; Moquereau C; Bitam S; Pranke I; Planelles G; Teulon J; Herrmann H; Roldan A; Zielenkiewicz P; Dadlez M; Lukacs GL; Sermet-Gaudelus I; Ollero M; Corringer PJ; Edelman A
    J Mol Biol; 2016 Jul; 428(14):2898-915. PubMed ID: 27241308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA.
    Rozmahel R; Gyömörey K; Plyte S; Nguyen V; Wilschanski M; Durie P; Bear CE; Tsui LC
    Hum Mol Genet; 1997 Jul; 6(7):1153-62. PubMed ID: 9215687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and phenotype in cystic fibrosis.
    Zielenski J
    Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.
    Wang F; Zeltwanger S; Hu S; Hwang TC
    J Physiol; 2000 May; 524 Pt 3(Pt 3):637-48. PubMed ID: 10790148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis.
    Kraus C; Reis A; Naehrlich L; Dötsch J; Korbmacher C; Rauh R
    Cell Physiol Biochem; 2007; 19(5-6):239-48. PubMed ID: 17495464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.
    Srivastava M; Eidelman O; Pollard HB
    Mol Med; 1999 Nov; 5(11):753-67. PubMed ID: 10656877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very mild disease phenotype of congenic CftrTgH(neoim)Hgu cystic fibrosis mice.
    Tóth B; Wilke M; Stanke F; Dorsch M; Jansen S; Wedekind D; Charizopoulou N; Bot A; Burmester M; Leonhard-Marek S; de Jonge HR; Hedrich HJ; Breves G; Tümmler B
    BMC Genet; 2008 Apr; 9():28. PubMed ID: 18400105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.
    Kälin N; Claass A; Sommer M; Puchelle E; Tümmler B
    J Clin Invest; 1999 May; 103(10):1379-89. PubMed ID: 10330420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations.
    Delaney SJ; Alton EW; Smith SN; Lunn DP; Farley R; Lovelock PK; Thomson SA; Hume DA; Lamb D; Porteous DJ; Dorin JR; Wainwright BJ
    EMBO J; 1996 Mar; 15(5):955-63. PubMed ID: 8605891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
    Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.